Biogen has finalised a $900 million payment to settle a whistleblower lawsuit claiming that it paid kickbacks to US doctors to prescribe its multiple sclerosis drugs. According to a Department of ...
In this article, Hardik Singhvi discusses the new trend in direct to patient selling by pharmaceutical companies, in order to reduce wastage and move manufacturers nearer to where the patients are, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback